Not applicableEnded earlyNCT07449234What this trial is testingGuselkumab After Switching From Ustekinumab in Participants With Moderate to Severe PsoriasisWho this might be right forPsoriasis Janssen-Cilag Ltd. 9
Large-scale testing (Phase 3)Ended earlyNCT04856787What this trial is testingA Clinical Studyf of SHR-1701 or Placebo in Combination With BP102 and XELOX in the First-line Treatment of mCRCWho this might be right forMetastatic Colorectal Cancer (mCRC) Suzhou Suncadia Biopharmaceuticals Co., Ltd. 62
Not applicableStudy completedNCT02922192What this trial is testingIncidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive AnalysisWho this might be right forRheumatoid ArthritisInflammatory Bowel DiseasePsoriasis+2 more Biologics & Biosimilars Collective Intelligence Consortium 90,360
Early research (Phase 1)Not Yet RecruitingNCT07517289What this trial is testingStudy to Determine the Comparative Pharmacodynamics of Enoxaparin Sodium Biosimilar With That From ClexaneWho this might be right forHealthy Participants StudyThe Focus of the Study is to Determine the Comparative Pharmacodynamic of Enoxaparin Sodium With That of Clexane in Healthy Human Participants Egyptian International Pharmaceutical Industries Co 26
Early research (Phase 1)Study completedNCT04601389What this trial is testingStudy of Pharmacokinetics, Pharmacodynamics and Safety Assessment of GNR-044 (JSC GENERIUM, Russia) and Xolair®Who this might be right forHealthy Volunteers AO GENERIUM 84
Not applicableStudy completedNCT02158169What this trial is testingBiosimilar Retacrit® in the Treatment of Chemotherapy-induced Anaemia in Oncology and HaematologyWho this might be right forChemotherapy-induced Anemia Hospira, now a wholly owned subsidiary of Pfizer 2,167
Large-scale testing (Phase 3)Study completedNCT02115750What this trial is testingComparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)Who this might be right forRheumatoid Arthritis Coherus Oncology, Inc. 647
Not applicableActive Not RecruitingNCT07221890What this trial is testingA Trial of Academic Detailing to Promote Prescribing of BiosimilarsWho this might be right forAutoimmune DiseasesRheumatoid Arthritis (RA)Inflammatory Bowel Disease (IBD)+1 more Brigham and Women's Hospital 1,325
Testing effectiveness (Phase 2)UnknownNCT04670978What this trial is testingAbraxane With Bevacizumab Biosimilar in Patients With Recurrent, Platinum-resistant Epithelial Ovarian CancerWho this might be right forObjective Response Rate Shandong University 96
Testing effectiveness (Phase 2)UnknownNCT05883176What this trial is testingTACE Combined With Bevacizumab in HCC (BCLC-B) Beyond Up-To-Seven CriteriaWho this might be right forHepatocellular Carcinoma by BCLC Stage Sun Yat-sen University 35
Early research (Phase 1)Study completedNCT03857230What this trial is testingThe Safety and Pharmacokinetics of Primapur and Gonal-fWho this might be right forArea Under CurvePharmacokineticsAbsorption IVFarma LLC 28
Testing effectiveness (Phase 2)Study completedNCT02121353What this trial is testingSafety Study of PF582 Versus Lucentis in Patients With Age Related Macular DegenerationWho this might be right forAge Related Macular Degeneration (AMD) Pfenex, Inc 25
Large-scale testing (Phase 3)Study completedNCT03259074What this trial is testingEffect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar)Who this might be right forAnkylosing Spondylitis Novartis Pharmaceuticals 859
Early research (Phase 1)Looking for participantsNCT07176650What this trial is testingPhase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma (HCC) Shanghai Henlius Biotech 246
Large-scale testing (Phase 3)UnknownNCT05419427What this trial is testingDenosumab Biosimilar Injection in Post Menopausal Women With OsteoporosisWho this might be right forOsteoporosis, Postmenopausal Lambda Therapeutic Research Ltd. 552
Early research (Phase 1)Study completedNCT04408989What this trial is testingA Study Comparing the Pharmacokinetic Similarity of MB02-SP, MB02-DM and US Licensed-Avastin®.Who this might be right forHealthy Volunteers mAbxience Research S.L. 114
Early research (Phase 1)Study completedNCT03293654What this trial is testingA Pharmacokinetic Study Comparing MB02 And US And EU Avastin® In Healthy Male VolunteersWho this might be right forHealthy Volunteers mAbxience Research S.L. 114
Testing effectiveness (Phase 2)Active Not RecruitingNCT06591273What this trial is testingEfficacy and Safety of Infliximab Biosimilar in Treatment of Moderate to Severe Psoriasis; A Single-arm Clinical TrialWho this might be right forModerate to Severe Chronic Plaque Psoriasis Services Institute of Medical Sciences, Pakistan 104
Large-scale testing (Phase 3)WithdrawnNCT02768714What this trial is testingTrial to Compare the Efficacy and Safety of Pegfilgrastim Biosimilar in Subjects With High Risk Stage Breast Cancer Receiving ChemotherapyWho this might be right forBreast Cancer Eurofarma Laboratorios S.A.
Large-scale testing (Phase 3)Study completedNCT02722044What this trial is testingUsability of an AI for M923 in Subjects With Moderate to Severe RAWho this might be right forRheumatoid Arthritis Momenta Pharmaceuticals, Inc. 33